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Receptors that specifically recognize and bind the Fc region of the IgG molecule 
have been described on a large number of cells. These receptors, which are called Fc'y 
receptors,  have  been  identified  on  B  lymphocytes  (1),  some  T  lymphocytes  (2), 
polymorphonuclear cells  (3),  macrophages  (4), mast  cells  (5),  herpes virus-infected 
cells  (6),  and  placental  syncitiotrophoblasts  (7).  With  the  exception of antibody- 
dependent cell-mediated cytotoxicity (8) and immunophagoeytosis (9), the biological 
role of Fc  7 receptors is still unclear. Knowledge of the physicochemical properties of 
Fc  7 receptors might (a) clarify whether the Fc7 receptors of the different types of cells 
are uniform or different in structure, (b) open up new possibilities for elucidating yet 
unknown  functions of Fcy receptors, and  (c)  shed  light  on  the relationship of Fcy 
receptors to other membrane proteins  (10).  Therefore, several attempts  have  been 
made to define the physicochemical structure of Fcy receptor molecules. The studies 
performed so far, however, have not yielded consistent data. In particular, the tool wt 
estimated  by  various  authors  (11-18)  varied  between  15,000  and  130,000.  These 
inconsistent  estimates  of the  molecular  weight  might  reflect  an  actual  structural 
heterogeneity of Fc  7 receptors on different types of ceils or from different species, or 
they might be just technical artifacts. In an attempt to clarify this question, we have 
started  to obtain  data on the solubilization and  physicochemical properties of Fc~, 
receptors of B cells. To be sure of investigating structurally uniform Fc~, receptors, we 
decided to first look at the Fcy receptors in a  B-type prolymphocytic leukemia and 
two cases of B-type chronic lymphocytic leukemia. 
In this paper, we report on the solubilization, isolation, and some characteristics of 
a  protein with  the properties of Fcy receptors that  was  obtained  from  the  B-type 
lymphoid leukemia cells. Because some of the physicochemical properties of the Fcy- 
binding protein we isolated were comparable to those of Clq or its subunits (19,  20), 
experiments were performed to clarify whether the isolated Fcy receptor-like protein 
is identical with Clq or parts of it. 
Materials and Methods 
Leukemic Cells.  Large numbers of leukemic cells were obtained by leukopheresis from one 
patient with chronic lymphocytic leukemia (CLL) l of the B type, one patient with prolympho- 
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cytic leukemia (PLL)  of the B type, and one patient with CLL of the T  type. In a second case 
of B-type CLL, the leukemic cells were prepared from the patient's spleen (1,500 g), which was 
heavily infiltrated by leukemic cells,  by pressing the splenic tissue through  a  nylon mesh, 
followed  by Urografin-(E. R. Squibb & Sons, New York)  Ficoll (Pharmacia Fine Chemicals, 
Inc., Uppsala, Sweden) gradient centrifugation of the cells (21). The lymphocytes from the two 
cases of B-type CLL expressed  small amounts of surface immunoglobulin  (SIg), bore receptors 
for erythrocytes coated with IgM antibodies and C3d  (EAC3d) and mouse eryth,  rocytes (E), 
but lacked receptors for sheep E and E coated with IgM antibodies and C3b (EAC3b). The 
PLL cells showed a thick layer of IgM/K and Clq on their surface and receptors for EAC3b 
and EAC3d, but lacked receptors for mouse E and sheep E. The cells from all three B-type 
leukemias bound IgG aggregates and ox E coated with anti-E antibodies of the IgG type (IgG- 
EoxA) in a percentage ranging from 40 to 95%. Sheep E coated with anti-E antibodies of the 
IgM type (IgM-EA) were not bound by the leukemic B cells. The T-type CLL cells were SIg 
negative and Ia-like-antigen  negative and did not bind aggregated IgG-fluorescein isothiocya- 
nate (FITC) or IgG-EoxA, but formed rosettes  with sheep E at 4°C. 
lgG Aggregates.  Human IgG was prepared from pooled human sera by fractionation with 
ammonium-sulfate  precipitation followed by chromatography on DEAE-cellulose equilibrated 
with 0.0175  M  phosphate buffer, pH 7.0. The IgG (20 mg/ml) was aggregated by heating at 
63°C for 28 min (22). Soluble IgG aggregates with a mol wt between 2.5  ×  107 and 3  ×  107 
were  obtained by chromatography on a  Sepharose 2B column (Pharmacia Fine Chemicals, 
Inc.,  100  ×  1.5  cm)  calibrated with  IgG,  IgM,  and  dextran  blue; and equilibrated with 
phosphate-buffered saline (PBS). 
F(ab')~  Aggregates.  F(ab')2  fragments  were  prepared  by  cleaving IgG  with  pepsin  and 
purification on a  Sephadex G-150 column (Pharmacia Fine Chemicals, Inc.,  100  X  2.5 cm) 
(23). Soluble F(ab')~ aggregates were obtained by the same procedure as that described for IgG 
aggregates. 
Soluble Peroxidase-  Anti- Peroxidase-  lgG  (PAP- IgG  )  and  - F (ab'  ) e  (PAP- F[ab  "  ]~ )  Complexes. 
Soluble PAP-IgG complexes consisting of three molecules of horseradish peroxidase and two 
molecules of rabbit anti-peroxidase IgG-type antibodies were  obtained from Dakopatts A/S, 
Copenhagen, Denmark. Fc fragments were cleaved from PAP-IgG with pepsin. The resulting 
PAP-F(ab')2  complexes were purified on a calibrated Uhrogel AcA 22 column (LKB Produkter, 
Bromma, Sweden, 100 ×  2.5 cm). 
Preparation of Uncoated  E Membrane Sheets and those Coated  with IgG.  1 ×  109 sheep E (E~) were 
incubated at 37°C for 30 min in 3 ml of the IgG fraction of a rabbit anti-Es serum with an 
agglutination titer of 1:32,000. The strongly agglutinated E~ were washed twice in PBS.  The 
ag~glutinated E, and 1 X  I0  ~ untreated E~ were homogenized by nitrogen cavitation (1,400 lb/ 
in, 20 min). The resulting membrane sheets were then washed several  times and homogenized 
with a Potter-Elvehjem homogenizer until all contaminating hemoglobin was removed. 
Coupling of Proteins to Sepharose 4B.  Proteins were  coupled to cyanogen bromide (CNBr)- 
activated Sepharose 4B as described by Cuatrecasas et al. (24). 
Radioiodination.  Proteins and purified cell  membranes were labeled with  125I (Amersham 
Buchler Radiochemicals, Braunschweig, West Germany) using chloramine T  (25). The cell 
membranes of intact cells were enzymatically iodinated with lactoperoxidase (1 mCi 125I/1 × 
108 cells)  (26). Unbound x~5I was  removed by passage over a  Sephadex G-25 column or by 
exhaustive washing. 
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Isolation of Cell Membranes.  Cells were homogenized by nitrogen cavitation (800 lb/in  2, 20 
min), and membranes were pelleted at 105,000 g for 60 rain after differential centrifugation at 
600 g and 20,000 g for 30 min (27). 
Preparation of CeU-Membrane Lysate.  Purified  membranes  were  incubated  in  80  mM  Na- 
EDTA/50 mM 2-mereaptoethanol (ME)  (EDTA-ME)  in 20 mM Tris-HCl, pH  7.3,  or 0.1% 
Nonidet P-40  (NP-40, Shell Chemical Co., New York) in 20 mM Tris-HCl, pH  7.3,  or 0.5% 
sodium deoxycholate (DOC) in 20 mM Tris-HCl, pH 7.3, at 4°C for 20 min. Insoluble material 
was removed by centrifugation at  105,000 g for 60 rain. The supernate was used immediately. 
Isolation of Fcy-binding Protein.  Iodinated membrane lysates obtained from 2 ×  l0  s cells were 
routinely  incubated  with  IgG  aggregates  or,  in  some  experiments, with  soluble  PAP-IgG 
complexes at 37°C for 30 minutes and then coprecipitated with a sheep anti-human IgG serum 
or a sheep anti-rabbit IgG serum, respectively. The coprecipitates were exhaustively washed. In 
some  experiments,  IgG  aggregates  or  F(ab')2  aggregates  were  incubated  with  12~I-labeled 
membrane lysates and separated from unbound membrane proteins by chromatography on a 
calibrated Sepharose 2B column. In other experiments, Fcy-binding proteins were isolated by 
incubating iodinated membrane lysates with IgG-coated E8 membrane sheets at 37°C for 30 
minutes, followed by exhaustive washing in 0.1 M Tris-HCl, pH 7.2. The material obtained by 
all of these methods was boiled in sodium dodecyl sulfate (SDS) sample buffer for 2 rain. In a 
third set of experiments, iodinated membrane lysates were incubated at 37°C for 30 rain with 
1 mg of either aggregated IgG, aggregated F(ab')2, PAP-IgG, or PAP-F(ab')2 coupled to 1 ml 
Sepharose 4B. After exhaustive washing in PBS, the pelleted Sepharose 4B was boiled in SDS 
sample buffer for 2 min. The absorbed material was separated from the Sepharose 4B matrix 
by passage through a Whatman GF/A filter (Whatman Chemicals, Div. of W. & R. Balston, 
Maidstone, Kent, England), followed by 10-fold concentration with Ultrathimbles (UH  100/ 
25;  Schleicher & Schiill GmbH, Dassel, West Germany). 
Isolation of Fcy-binding  protein by means of  column affinity chromatography was performed 
as follows. Aggregated IgG was coupled to CNBr-activated Sepharose 4B (24). After equilibra- 
tion with PBS, 12SI-labeled membrane lysate from 1 ×  109 cells was applied to the column and 
incubated at 22°C for 30 min. The column was washed in PBS until radioactivity decreased to 
the baseline; retained proteins were eluted with 0.1 M glycine-HCl buffer, pH 2.8. Eluates were 
neutralized and incubated with 0.1  mg aggregated IgG at 37°C  for 30 min. The incubated, 
aggregated IgG was isolated by copreeipitation as described above. 
SDS-Polyac,ylamide Gel Electrophoresis.  SDS electrophoresis was performed on cylindrical gels 
according to the method described by Laemmli (28).  The stacking and separating gel combi- 
nations  used  were  either  3.5%  and  7.5%,  or 3.5%  and  10%  polyacrylamide concentration. 
Samples were pretreated by heating for 2 min  in 2%  (wt/vol) SDS dissolved in gel-loading 
buffer, either with or without 100 mM ME. By adding 1 M iodoacetamide, the reduced samples 
were alkylated to a  final concentration of 100 raM. Unreduced human  IgG, reduced bovine 
serum albumin, y-chains, and reduced myeloma light (A) chains were routinely used as internal 
markers. After electrophoresis, the gels were sliced into  1-mm segments and radioactivity was 
determined in a y-counter (BF 5300,  Berthold GmbH, Wildbad, West Germany). 
Isoelectric Focusing.  Isoelectric focusing was performed in cylindrical 5% polyacrylamide gels 
in the presence of 6 M  urea. The gels contained 5% Ampholine (LKB Produkter)  in the pH 
ranges 3.5-10 (four parts) and 4-6 (one part). The pH gradient was established at  150 V  for 2 
h. Coprecipitates dissolved in 8 M urea were applied to gels and focused for 16 h at 150 V  and 
0.4-0.5 mA per gel. After focusing, the gels were cut into l-ram segments and radioactivity was 
determined. For determination of the final pH  gradient, two parallel gels were cut  into 20 
segments, and  the  pH  was  measured  in  the distilled water eluates of each segment  with a 
conventional pH meter. 
Determination of NH~Terminal Amino Acid.  Membranes  from  1  ×  101° lymphocytes were 
solubilized with EDTA-ME, and Fcy-binding proteins were isolated from membrane lysates by 
incubation with IgG aggregates and coprecipitation with sheep anti-human IgG serum. After 
exhaustive washing in 0.15 M Tris-HCl, pH 7.5, the complexes were dissociated by incubation 
in 0.1  M  citrate buffer, pH 2.8, for 20 rain at room temperature, followed by chromatography 
on an Uhrogel AcA-34 column. Fractions corresponding to a tool wt of 28,000 were collected, 
dialyzed against water, and lyophilized. Determination of the NH2-terminal amino acid was 
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layer chromatography of amino acids (29).  Dansylated amino acids were used as references 
(Serva Feinbioehemica, Heidelberg, West Germany). 
Complexes of E and Anti-E Antibodies of the IgG Type (IgG-EA).  Various IgG-EA complexes 
were prepared. IgG-EoxA was prepared by incubating ox E  (Eo~) in a  hyperimmune rabbit 
serum, which had a low Eox-agglutination titer and a high hemolysis titer, at 37°C for 30 min. 
Complexes of Rh-positive human type-O E (F-,hu) and human anti-E antibodies of the IgG type 
(IgG-EhuA)  were  prepared  by  incubating  Ehu  in  a  human  serum  containing  a  high  titer 
(indirect-Coombs-test  positive  to  a  final  dilution  of  1:2,000)  of  nonagglutinating  anti-D 
antibodies. Complexes of Es and  rabbit  anti-E antibodies of the  IgG  type  (IgG-EsA) were 
prepared by incubating E~ in the IgG fraction of a rabbit anti-E~ serum at a barely nonagglu- 
tinating titer. The highest percentage of rosettes and  the most-stable rosettes were obtained 
with IgG-EozA. IgG-EhuA yielded 20-60% and IgG-E~A, 40-95% lower percentages of rosetting 
cells. Thus, IgG-Eo~A was routinely used in our experiments. 
IgM-EA.  IgM-EA was prepared by incubating E~ in the IgM fraction of an anti-Es serum 
at  a  barely nonagglutinating titer.  The  IgM  fraction was obtained by fractionation of the 
antiserum  by  means  of ammonium-sulfate  precipitation  followed  by  passage  through  an 
Ultrogel AcA-34 column.  The  IgM nature  of the sensitizing antibodies was ascertained by 
titration of the IgM-EA against monovalent anti-rabbit IgM and anti-rabbit IgG sera (obtained 
from Nordic Immunological Laboratories, Tilburg, The Netherlands). 
Rosette Formation.  2 ×  106 leukemic cells were incubated with 8 ×  107 of IgG-EA complexes 
or IgM-EA in small plastic conical tubes (Eppendorf GmbH,  Hamburg, West Germany) at 
37°C for 5 rain, followed by centrifugation at 200 g for 5 min and a second incubation at 37°C 
for 20 min. Afterwards, the cells were gently resuspended and kept on ice until counting. 
Rosette-inhibition Assay.  For detection of soluble Fcy-binding protein, IgG-Eo~A and/or IgG- 
EhuA were preincubated in EDTA-ME membrane lysate. The rosette assay was then performed. 
For detection of agents blocking membrane receptors, the rosette tests were performed either 
in the presence of the agents (monomeric IgG, IgG aggregates, PAP-IgG, 19S IgM, carrageenin, 
or polyinosinic acid; the latter two obtained from Sigma Chemical Co., St. Louis, Mo.) or after 
preincubation of the leukemic cells with the agents (anti-C 1  q serum or anti-Fcy-receptor sera), 
followed by two washings. The inhibition of rosette formation was calculated with the method 
of Dierich and Reisfeld (30). 
Binding of PAP-IgG.  5  ×  108 leukemic cells were incubated at 37°C for 30 rain with 50/~1 
PAP-IgG at various dilutions. After three washings, centrifuge slides were prepared and fixed 
in a  1% PBS-buffered glutaraldehyde solution for 1 min, followed by two washings in 0.05 M 
Tris-HCl buffer, pH 7.6. The slides were then incubated at 22°C for I0 min in Tris-HCl buffer 
containing  3',3'-diaminobenzidine tetrahydrochloride  (Sigma  Chemic,  Munich,  West  Ger- 
many)  (0.5  mg/mi,  pH  7.6)  and  0.001%  HzO2.  After  several  washings,  the  slides  were 
counterstained  with  hemalum  and  mounted  with  Eukitt  (Odelie  Kindler,  Freiburg, West 
Germany). 
Antisera.  Anti-Fcy-receptor sera  were  prepared  as  follows.  IgG-EoxA was  incubated  in 
EDTA-ME membrane lysate from the case of PLL and washed twice. The coating of the IgG- 
EoxA with Fcy-binding protein was monitored by reduction of rosette formation. Three rabbits 
were immunized i.v. weekly with 5  X  l0  s of the incubated IgG-EoxA, which showed rosette 
formation reduced by at least 60%. Blood was obtained weekly, starting 1 mon after the first 
immunization. The antisera were exhaustively absorbed with Eoz, Ehu, EB, and glutaraldehyde- 
insolubilized serum  protein,  and  partly  absorbed with  human  brain  homogenate  and  C1 
(Cordis Laboratories Inc., Miami, Fla.). The absorbed and diluted (1:30) anti-Fcy-receptor  sera 
showed IgG-EA-rosette inhibition of 60-80% when compared with 1:30-diluted normal rabbit 
serum, whereas they did not suppress the binding of EAC3b and neuraminidase-treated E, to 
appropriate cells. The anti-Fcy-receptor sera stained Fcy-receptor-positive leukemic cells, but 
not  cells from  T-type CLL,  thymocytes, T  cells of peripheral blood,  erythrocytes, or  Fcy- 
receptor-negative EU-I-eell line cells (kindly donated by Dr.  U.  Schneider, Erlangen, West 
Germany) in indirect immunofluorescence. 
Sheep anti-human IgG serum and sheep anti-rabbit IgG serum were produced by immuniz- 
ing sheep with purified human IgG or rabbit IgG by means of the procedure of Hijmans et al. 
(31). The anti-human IgG serum was absorbed with Eh~, human brain homogenate, PLL cells, JOCHEN THOENES AND HARALD STEIN  1053 
and  glutaraldehyde-insolubilized  purified  IgM. This antiserum  agglutinated  only E coated 
with human IgG and not E coated with other proteins. The anti-rabbit IgG serum was absorbed 
with glutaraldehyde-insolubilized  human serum polymer, Ehu, and PLL cells. 
Anti-Eo~ sera containing a large amount of IgG antibodies  were obtained by immunizing 
rabbits  i.v. weekly with  1  ×  101° Eox  for  3  mon.  Only  the  anti-Eox sera  showing  a  low 
agglutination titer (1:4-1:8) and a high hemolysis titer (1:2,000, demonstrated by adding 1:64- 
diluted  guinea pig serum) were used. 
Anti-E8 sera with  a high content of IgM antibodies  were prepared by immunizing rabbits 
i.v. with  1 ×  10  a° E8 three times per wk for 3 wk. The first blood sample was taken and tested 
on the 14th d after the first immunization.  The sera with the highest ME- (final concentration 
of 0.1 M) sensitive agglutination titers were pooled. 
Anti-E~ sera with  a high content of IgG antibodies  were obtained by immunizing rabbits 
weekly with  1 ×  10 I° E~ for 3 mon. The |gG fraction was isolated as described for human IgG. 
The nonagglutinating human anti-D serum was a generous gift from Dr. Sachs, Blutspen- 
dezentrale,  University  of Kiel,  Kiel, West  Germany.  Anti-Clq  serum  was  obtained  from 
Behring Werke AG, Marburg/Lahn, West Germany. 
Immunofluorescent Staining.  IgG aggregates  were  conjugated with  FITC  according to  the 
method of Clark and Shepard  (32). Goat anti-rabbit IgG-rhodamine isothiocyanate  conjugate 
(Nordic Immunological Laboratories) was additionally  absorbed with human tonsil cells before 
use  in  the  indirect  procedure.  The staining  procedure  described  by Vossen  (33) was used. 
Control  stainings  performed  with  normal rabbit serum  absorbed  with  Ehu, tonsil cells, brain 
and  serum  polymer,  and  an  anti-arfetoprotein  serum  (Dakopatts  A/S)  were  completely 
negative  at  dilutions  higher  than  l:15.  The anti-Fcy-receptor  sera  were  usually  used  at  a 
dilution  of 1:20 for indirect  immunofluorescence. 
Results 
Properties of the Cell-bound Fcy Receptor.  A  large proportion  (40%,  70%,  and  95%, 
respectively)  of cells  from  the  three  B-type  leukemias  bound  FITC-labeled  IgG 
aggregates, IgG-EoxA, and PAP-IgG; a smaller proportion bound IgG-EhuA and IgG- 
E~A, but none bound IgM-EA. Cells from the case of T-type CLL and Ehu, both of 
which were used as control cells, neither bound detectable amounts of IgG aggregates 
labeled with FITC, nor of PAP-IgG, nor formed rosettes with IgG-EoxA. As shown in 
Fig.  1, the binding of IgG-Eo~A to the leukemic B cells decreased with the addition of 
increasing amounts of IgG aggregates and monomerie IgG. A  200-fold molar excess 
of monomeric IgG was needed  to achieve an  inhibitory effect on IgG-Eo~A-rosette 
formation similar to that of IgG aggregates. IgG-Eo~A-rosette inhibition by monomeric 
IgG did not exceed 80%, even with 1.5 mg monomeric IgG. Nearly complete inhibition 
of IgG-EoxA-rosette formation could be obtained only with IgG aggregates. A similarly 
marked rosette inhibition  was observed with  PAP-IgG. IgG-EoxA-rosette formation 
was not affected by the presence of purified IgM, carrageenin, or polyinosinic acid, or 
by preincubation of the  leukemic cells with  anti-Clq  serum.  Preincubation  of the 
leukemic  cells  with  diluted  (1:30)  anti-Fcy-receptor sera,  however, decreased  IgG- 
Eo~A-rosette  formation by >70% when compared with normal rabbit serum, whereas 
it did not affect rosette formation with EAC3b. 
Solubilization  of Fcy  Region-spec~'c Protein and  Properties of the  Solubilized Molecules. 
First,  we solubilized membranes of the leukemic B cells,  obtained by rupturing the 
cells by means of the nitrogen cavitation method and differential centrifugation, with 
NP-40. After iodination, the membrane lysates were incubated with IgG aggregates 
and then coprecipitated with an anti-IgG serum. SDS-polyacrylamide gel electropho- 
resis of the coprecipitates revealed six major peaks with mol wt ranging from 15,000 10- 
20-111 
C 
"O 
¢- 
! 
< 
ILl 
FcT-BINDING PROTEIN  FROM  LEUKEMIC B CELLS  1054 
30" 
40" 
o  50" 
c 
o 
~  60 
t- 
O  70' 
o 
80 
90- 
100 
100  200  300  400  500 
pg  protein  added 
Flc.  1.  Inhibition of binding of IgG-EoxA to  prolymphocytic leukemia cells by  addition of 
aggregated IgG (p.g) (0) and monomeric  IgG (#g) (V) in weights equal to those &aggregated IgG; 
and monomeric  IgG (ll) in amounts equimolar to aggregated IgG calculated from the mol wt of the 
aggregated IgG of 3 X 10  7, 
to  115,000  (Fig.  2,  solid  line).  A  basically  similar  SDS  pattern  was  obtained  with 
F(ab')2 aggregates  (Fig.  2, dotted  line).  An Fc7 region-specific protein could not  be 
coprecipitated from DOC-solubilized membranes either.  These disappointing results 
encouraged us to try nondetergent agents. Good results were obtained with a mixture 
of EDTA  and  ME.  EDTA-ME  membrane  lysates  dialyzed  against  PBS  strongly 
inhibited  the  binding  of IgG-Eo~A to  leukemic  B  cells.  The  inhibition  was  dose- 
dependent  (Fig.  3).  Even highly concentrated  EDTA-ME  lysates, however, did  not 
agglutinate IgG-EoxA. Absorption of the membrane lysates with  IgG-EoxA, but  not 
with  uncoated  Eox, removed  the  capacity  of the  membrane  lysates  to  inhibit  the 
binding of IgG-EoxA to leukemic B cells. 
Isolation of the IgG-binding material from EDTA-ME  lysates of the  leukemic B 
cells was performed by (a)  coprecipitation  with  IgG aggregates,  (b)  coprecipitation 
with PAP-IgG complexes, (c)  absorption with E  membrane sheets coated with IgG- 
type antibodies, (d) absorption with aggregated IgG and PAP-IgG complexes coupled JOCHEN  THOENES  AND  HARALD  STEIN 
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F~o.  2.  SDS  polyacrylamide  gel  profiles of iodinated  membrane  proteins solubilized  with 0.1% 
NP-40 in 20 mM Tris-HCl and isolated with IgG aggregates (  ) or F(ab')2 aggregates (...). 
to Sepharose 4B, and (e)  affinity chromatography on aggregated IgG-Sepharose 4B 
columns. SDS preparations from all types of material revealed identical patterns in 
SDS-polyacrylamide gel electrophoresis, viz.: one small-based peak with an apparent 
mol wt of 28,000  (Figs.  4  and 5,  solid lines).  The highest peak was obtained with 
PAP-IgG (not shown). An identical protein peak was isolated from membranes that 
had been prepared from surface-iodinated viable leukemic B cells, which confirmed 
that the isolated protein was a  cell-surface protein. Reduction and alkylation of the 
Fc2,-binding protein did not affect its relative mobility; its NH2-terminal amino acid 
was determined to be glycine. Thin-layer chromatography of the dansylated receptor 
protein not subjected to acid hydrolysis did not show a  fluorescent spot representing 
noncovalently bound glycine. 
Material  with  binding  affinity to  aggregated  or  c0mplexed  IgG  could  not  be 
isolated from lysates of iodinated and  isolated membranes of cells from a  human 
leukemia  of the  T  type or  Ehu  (Fig.  6,  dotted  and  solid  lines).  Furthermore,  no 
electrophoretic peak at all could be obtained with EDTA-ME  lysates of the mem- 
branes of the B-type leukemia cells (Figs. 4 and 5, dotted'lines) when F(ab')2 aggregates 
were used instead of IgG aggregates, when PAP-F(ab')2 complexes were used instead 
of intact PAP-IgG molecules, or when uncoated E membrane sheets were used instead 
of IgG-coated E membrane sheets. 
Attempts to elute Fcy-binding protein, without denaturation, from aggregated IgG- 
Sepharose 4B columns with 0.1 M  glycine-HC1, pH 2.8, yielded only small amounts 
of iodinated material when compared with eluates obtained with SDS. Coprecipita- 
tion of the glycine-HC1 eluates with IgG aggregates gave a  small, but distinct peak 
corresponding to a tool wt of 28,000. 
Isolation of the 28,000-dalton  protein with IgG aggregates was not inhibited by I056 
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FEG. 3.  Inhibition  of binding  of IgG-EoxA to  prolymphocytic  leukemia  cells by  EDTA-ME 
membrane lysate. IgG-EoxA was  preincubated  in  increasing  amounts of the  membrane lysate, 
washed twice, and rosetted with  leukemic cells. The membrane lysate showed a dose-dependent 
inhibition of rosette formation. 
earrageenin  (500/zg/ml)  or polyinosinic  acid  (500/tg/ml). 
Significant  amounts  of  Fcy-receptor-like  protein  were  solubilized  only  with  a 
mixture  of EDTA  and  ME  (Fig.  7,  dotted  line).  With  EDTA  (not  shown)  or  ME 
alone,  no,  or  only  very small  amounts  of,  FcT-receptor-like  protein  was  solubilized 
(Fig.  7, solid line), showing that both the ,removal of divalent cations and dissociation 
of disulfide bridges are necessary for liberation of the FcT-receptor molecules from the 
membranes. 
To obtain  data on the  FcT-receptor-like  molecules  under  nonreducing  conditions, 
we dialyzed EDTA-ME  lysates against oxygenated  PBS supplemented  with protease 
inhibitors.  Coprecipitates  obtained  from the dialysate with IgG aggregates displayed 
two  new  peaks  in  SDS-polyacrylamide  gel  electrophoresis  performed  under  nonre- 
ducing  conditions,  viz.:  a  large  peak  with  an  apparent  tool  wt  of  115,000  and  a 
smaller one with an apparent tool wt of 18,000 (Fig. 8). The 115,000-dahon  component 
could be readily dissociated  into a  28,000-dahon  protein by adding  ME. 
The isoelectric-focusing  pattern  of total  EDTA-ME  membrane lysates is shown in 
Fig. 9 A. Twelve distinct  peaks are discernible.  After absorption of the lysate with IgG 
aggregates  followed  by precipitation  with  anti-IgG  serum,  one  maior  peak with  an JOCHEN  THOENES  AND  HARALD STEIN 
CPM xlO -3 
o  o 
IgG  H  o.  L 
•  •  (%1  •  11 
9 
7 
5 
3 ¸ 
1- 
•  .°  .."""""'-**~  ~..,-..,  .. 
i  v  J  i  i  i  i  i  i  i 
20  40  60  80  100 
Segment  NO 
FIG. 4.  SDS polyacrylamide  gel profiles ofiodinated membrane proteins solubilized with EDTA- 
ME and isolated with IgG aggregates (  ) or F(ab')2 aggregates (...). H, heavy chains of IgG. L, 
light chains of IgG. 
1057 
CPM xlO -2  o 
o 
20 !  H  o.  L  •  ¢~I  • 
15- 
10 
i  "  "%  ""  t  V~  ~  ~...,.,  ........  ..  .........  j 
i  |  w  i  i  i  i  v  v  i 
20  40  60  80  100 
Segment  N ° 
FIG. 5.  SDS polyacrylamide  gel profiles of iodinated membrane proteins from B-type prolympho- 
cytic leukemia cells solubilized with EDTA-ME and isolated with IgG-coated E~ membrane sheets 
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isoelectric point (pI) of 5.5 was missing (Fig. 9 B). The missing peak, representing the 
Fc),-affined protein, with a  pI of 5.5 could be recovered by isoelectric focusing of the 
coprecipitate (Fig. 9C). 
Electrophoretic Pattern of Clq Solubilized with EDTA-ME and Isolated with IgG Aggre- 
gates.  Because some of the properties of the Fcy-binding protein resembled those of 
C lq, we analyzed the SDS electrophoretic pattern of C lq isolated from C 1 under the 1058  Fcy-BINDING  PROTEIN  FROM  LEUKEMIC  B  CELLS 
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Fro.  6.  SDS  polyacrylamide  get  profiles  of iodinated  membrane  proteins  from  T-type  chronic 
lymphocytic leukemia cells (  ) and Ehu (.. -) solubilized with EDTA-ME and isolated with IgG 
aggregates. 
same conditions as those for isolation of the Fc), receptor. As demonstrated in Fig. 10, 
C 1  q bound to IgG aggregates showed a major peak of 58,500 daltons, four very small 
peaks of 41,000,  34,000,  28,000,  and  20,000  daltons,  and  a  large  peak of <t0,000 
daitons. 
Detection of Clq and Fcy-Receptor Protein in EDTA-ME Membrane Lysates.  To deter- 
mine whether the EDTA-ME lysates contain C lq or its subunits with the capacity to 
bind  complexed IgG,  we  incubated  Ehu  and  Ehu  densely coated  with  incomplete 
human anti-D antibodies (EhuA) in EDTA-ME lysates. The incubated Ehu and EhuA 
were stained  for Clq by means of indirect immunofluorescence. To show that  Fcy- 
receptor protein is bound by EhoA, we stained the incubated Eh~ and EhuA with three 
different anti-Fcy-receptor sera prepared as described in Material and Methods;  in 
addition, we analyzed the reduction of binding of the incubated EhuA to leukemic 
cells in comparison with the binding of nonincubated EhuA. The results are shown in 
Table I. The binding of Fcy-binding protein to the Eh~A is evidenced by (a) the strong 
inhibition of rosette formation and  (b)  the positive staining of the incubated  EhuA 
with all  three anti-Fcy-receptor sera.  The capacity of the anti-Fcy-receptor sera to 
stain incubated Eh,A could not be removed by absorption of the antisera with Clq. 
Anti-Clq serum did not stain  IgG-EA complexes loaded with Fcy-binding protein. 
This suggests that the Fcy-affined protein solubilized with EDTA-ME is not related 
to Clq. 
Discussion 
The Fcy receptors on the  cells from the  three B-type leukemias we  investigated 
were detectable with FITC-labeled IgG aggregates, PAP-IgG, and IgG-EA complexes. 
Studies of inhibition of IgG-EA-rosette formation by IgG aggregates, PAP-IgG, and 
monomeric IgG showed that IgG aggregates and PAP-IgG strongly inhibit IgG-EoxA- 
rosette formation and that a >200-fold molar excess of monomeric IgG is needed to 
cause  rosette  inhibition  comparable  to  that  obtained  with  IgG  aggregates.  This 
suggests that (a) the Fcy receptors on the cells from the three cases of B-type leukemia 
were  detectable with  IgG  aggregates,  PAP-IgG,  and  IgG-EoxA;  and  (b)  these  Fcy 
receptors preferentially bound complexed IgG. 
In isolation studies of the Fcy receptor, we first used NP-40 as the solubilization JOCHEN  THOENES AND HARALD STEIN 
C PI',4 xlO -2 
12- 
~o-  i 
8  I 
6-  ti 
-  "  i  ,,. 
"7  lZ,  2'1  2'8  3'5  4'2  4'9  5'6  6'3 
Segment  N£ 
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gates and solubilized with EDTA-ME  (...)  or ME alone (  ). 
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agent. We were not able to select an FcT region-specific protein, however, from the 
NP-40  membrane lysates of leukemic B  cells.  Six SDS-electrophoretically identical 
proteins were isolated with IgG aggregates and F(ab')2 aggregates. The mol wt of the 
six proteins ranged from 115,000 to 15,000. This finding indicates that NP-40 liberates 
proteins  that  can  be  bound  to  both  F(ab')2  and  IgG  aggregates.  F(ab')2-affined 
membrane  proteins  were  recently  described  (34,  35).  It  is  not  clear  why  similar 
proteins were isolated from NP-40 lysates with IgG and F(ab')z aggregates. A possible 
explanation is that the six isolated proteins are associated by NP-40 to a complex, or 
that  they  chiefly represent  a  membrane  complex  that  includes  proteins  with  an 
affinity  to  bind  to  aggregates  of IgG  and  F(ab')2.  This  heterogeneous  complex 
precipitates with IgG and F(ab')2 aggregates as a  single entity and  is reduced to its 
individual protein components when the precipitates are prepared for SDS electro- 
phoresis.  Because  we  obtained  similar  nonspecific  results  with  DOC  lysates,  we 
concluded that detergents are not suitable for the solubilization and isolation of Fcy- 
receptor molecules. We therefore tried nondetergent solvents. These have the advan- 
tage that they do not lysate antibody-coated indicator cells (EA). Using the mixture 
of EDTA and ME described by Rask et al.  (11)  as a  potent solvent of Fcy-receptor 
molecules, we could solubilize material from membranes of the leukemic B cells that 
strongly inhibited  the  binding of IgG-EoxA to Fcy-receptor-positive leukemic cells. 
The inhibitory activity was readily removed by exhaustive absorption of the EDTA- 
ME solubilisate with IgG-EoxA, but not with Eox. This eliminates the possibility that 
EA-rosette  formation  was  suppressed  either  nonspecificaUy  or  by  contaminating 
amounts of cytophilic IgG. The findings justify the conclusion that  the inhibitory 
activity of the lysate actually represents solubilized Fcy-binding protein. 
Because of the reported susceptibility of solubilized Fcy-receptor-like material  to 
proteolysis (17), we started the isolation procedure with EDTA-ME membrane lysates 
immediately after iodination, without removing the unbound iodine by dialysis. The 
free iodine was removed by exhaustive washing in PBS after absorption or coprecip- 
itation of the lysates with the substrates.  Various methods and substrates were used 
for isolation of proteins with the capacity to bind to the Fc portion of IgG, viz.: co- 
precipitation with aggregated IgG and antigen-antibody complexes (PAP-IgG), ab- 
sorption with IgG-coated E  membrane sheets, absorption with aggregated IgG and 1060  Fcy-BINDING PROTEIN FROM LEUKEMIC B CELLS 
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eopreeipitated  with aggregated IgG after exhaustive  dialysis against oxygenated  PBS supplemented 
with protease inhibitors. 
PAP-IgG  complexes  attached  to  Sepharose  4B,  and  affinity  chromatography  on 
aggregated IgG-Sepharose 4B columns. Fundamentally identical results were obtained 
with all methods and substrates used: SDS electrophoresis revealed one peak corre- 
sponding  to  a  moi  wt  of 28,000.  The highest  peaks  were obtained with  PAP-IgG 
complexes. Affinity chromatography with glycine-HCl elution of the bound proteins 
yielded less significant peaks. When uncoated E membrane sheets, IgG-F(ab')~ aggre- 
gates, or PAP-F(ab')2 complexes were used for absorption, no peak could be found in 
SDS electrophoresis, showing the specific binding of the isolated protein to IgG and 
within the IgG molecule to the Fc region. Neither with IgG aggregates nor with PAP- 
IgG  complexes were  significant  amounts  of Fcy-affined protein  detectable  in  the 
EDTA-ME extracts of membranes from an Fcy-receptor-negative T-cell leukemia or 
Ehu. 
Isoelectric focusing of the isolated Fcy-affined protein showed a single peak with a 
pI of 5.5, indicating that the isolated 28,000-dalton protein was composed of homo- 
geneous polypeptide chains.  Because the relative mobility of the isolated protein in 
SDS electrophoresis was not altered after reduction and alkylation, we concluded that 
the  protein  consisted  of one  polypeptide chain.  Another  finding  in  favor  of this CPM xl0 "3 
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conclusion was  that  only one NH2-terminal  amino  acid  (glycine) was  detected on 
isolated Fcy-receptor protein. Even concentrated EDTA-ME lysates did not aggluti- 
nate  Eo,A,  suggesting  that  the  Fcy-receptor protein  we  solubilized  has  only one 
binding site. 
The failure to isolate any peaks discernible in SDS-polyacrylamide gel electropho- 
resis or isoelectric focusing with F(ab')2 aggregates demonstrates that  proteins with 
affinity to F(ab')2 are not liberated by EDTA-ME, whereas they are liberated by NP- 
40. 
It is interesting that significant amounts of Fcy-receptor protein were solubilized 
only with a mixture of EDTA and ME. With EDTA or ME alone, no, or only small 
amounts of, Fcy-receptor protein was solubilized. That suggests that divalent cations 
and disulfide bridges are involved in the linkage of the Fcy-receptor protein to the cell 
membrane.  Although  the  specificity of the  isolated  protein  for  the  Fc  region  of 
aggregated IgG was clearly demonstrated, we cannot conclude that  the protein was 
a  complete Fcy-receptor molecule. The isolated Fcy-receptor-binding protein might 
be bound to integral membrane proteins, which have yet to be identified, via disulfide 
bonds and divalent cations. Thus, we may merely conclude that the isolated protein 
represented at least the part of the Fcy receptor of leukemic B cells that is responsible 
for binding to the Fc portion of IgG. 
There  have  been  only  two  other  reported  attempts  to  solubilize  Fcy-receptor 
molecules with nondetergent agents. In the first study (11), a  mixture of EDTA and 
ME was used. The authors isolated IgG-binding molecules from murine spleen cells 
by absorption and desorption on a  Sephadex column to which IgG aggregates were 
attached. The eluted protein differed, however, in molecular weight  (68,000,  18,000, 
and  15,000)  from the protein we isolated. In the second study (14), cell membranes 
were solubilized with  lithium  diiodosalicylate. The authors  isolated three proteins 
with mol wt of 65,000, 45,000, and 28,000 from murine leukemia cells with monomeric 
IgG, and  an additional  protein with a  mol wt  of 125,000 with  antigen-complexed 
IgG. Only the  125,000-dahon protein was dissociated into two smaller subunits with 
mol wt of 74,000 and 60,000. 
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The  literature  contains  reports  on  four studies  (12,  16-18)  using  detergents  to 
solubilize IgG-binding proteins. The proteins isolated in those experiments differed 
greatly  in  mol  wt  (24,000-125,000)  and  in  their  susceptibility  to  reduction.  It  is 
notable,  however,  that  in  two  of those  studies  the  Fcy-binding  proteins  revealed 
apparent mol wt of 110,000 and  120,000, respectively, under nonreducing conditions. 
Two research groups (13,  15) looked for Fcy-binding material either spontaneously 
released  from  cells  or  released  by  shedding  with  IgG  aggregates  and  anti-IgG 
antibodies. One group (13) reported on the isolation of a 45,000-dalton protein from 
a  murine leukemia cell line (L1210) and the other (15)  on a  100,000-dalton protein 
from human lymphoid cell lines. 
On the whole, the data in the literature on Fcy-binding proteins are very confusing. 
Because the mentioned studies differed chiefly in cell sources and solvents, it is not 
clear  which  of these  parameters  is  responsible  for  the  differences  in  the  results. 
Furthermore, there is also the possibility of nonspecific interaction during the isolation 
procedure. For these reasons, we performed a large number of control experiments in 
the present study. As long as it is not possible to measure the biological effect induced 
by binding of ligands to Fcy receptors, the only way to test the specific binding of IgG 
to  Fcy receptors is  to perform control experiments with  F(ab')2  fragments of IgG. 
Such control experiments do not, however, rule out the possibility that aggregated or 
complexed IgG is bound to cell-membrane proteins that do not act as Fcy receptors, 
but  rather capture the IgG via  nonspecific hydrophobic interaction.  On  the other 
hand, this problem also arises with Fcy-receptor assays of intact lymphoid cells. 
As far as we know, none of the published studies contains a report on the isolation 
of a single polypeptide chain with a mol wt of 28,000 under reducing conditions. To 
enable a  comparison of the isolated Fcy-binding protein not only with the reduced 
Fcy-receptor-like molecules  described  by  other  authors  but  also  with  nonreduced JOCHEN  THOENES AND HARALD STEIN 
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Method of detection  Ehu*  EhuA* 
Rosette inhibition  NDll  70% 
Staining 
Anti-Fcy-receptor  serum 1 + GAR-R:I: 
Anti-Fcy-receptor  serum 2 + GAR-R 
Anti-Fc'y-receptor  serum 3 + GAR-R 
Anti-Fcy-receptor  serum 3§ + GAR-R 
Anti-Clq serum + GAR-R 
GAR-R 
+¶ 
+ 
+ 
+ 
* Incubated in EDTA-ME lysates. 
GAR-R, rhodamine-labeled  goat anti-rabbit IgG y-globulin. 
§ Anti-Fcy-receptor  serum 3, additionally  absorbed with C 1. 
II ND, not done. 
¶ +, positive fluorescence. 
molecules,  and  to  obtain  data  on  the  aggregation  properties  of the  IgG-binding 
protein  that  we  isolated,  we  dialyzed EDTA-ME  lysates against  oxygenated PBS. 
With this procedure, the FcT-binding protein changed its mol wt to 115,000, probably 
by forming tetramers. The  115,000-dalton  protein was  reminiscent of the  125,000- 
dalton peak of Cooper et al. (14), the 120,000-dalton peak of Bourgeois et al. (17), the 
110,000-dalton  peak of Frade  and  Kourilsky (16),  and  the  100,000-dalton peak of 
Molenaar  et  al.  (15).  The  Fcy-binding proteins  described  by those  authors  might 
correspond to the tetrameric FcT,-affined proteins that we isolated. This assumption 
would explain why the 100,000-dalton protein described by Molenaar et al. (15) was 
able to agglutinate EA and our 28,000-dalton peak was not. In its tetrameric form, 
the IgG-binding protein should be muhivalent and thus capable of agglutinating EA. 
We have started investigations of these possibilities. 
It has been reported that isolated C lq binds firmly to human lymphocytes (36) and 
thus might be responsible for the binding of IgG aggregates. To study the possibility 
of the Fcy-receptor molecule being identical with Clq,  we investigated one of the 
three B-type lymphoid leukemias that we used as sources of IgG-binding material, for 
the presence of C 1  q on the cell membrane. All of the cells from this ease (B-type PLL) 
showed  strong  staining  for  Clq  in  double-layer  immunofluorescence.  From  the 
following findings, we concluded that  Clq  and  the FcT-binding protein isolated in 
this study are different structures: (a) The cells from all three cases of B-type leukemia 
formed rosettes only with IgG-EA complexes (40-95%) and not with IgM-EA (0-3%). 
If the Fc~,-receptor activity of the leukemic cells were mediated by C lq, both IgG-EA 
complexes and IgM-EA would be bound, because Clq reacts with the Fc fragments 
of both  IgG and  IgM  (37).  (b)  EA-rosette formation by the Clq-bearing  leukemic 
cells was not  depressed by anti-Clq  serum, but  was remarkably inhibited by anti- 
Fcy-receptor sera. (c) Carrageenin or polyinosinic acid did not inhibit the binding of 
the 28,000-dalton protein to IgG aggregates;  these substances  are known to inhibit 
the  binding  of Clq  to  complexed  IgG  (37,  38).  (d)  In  SDS-polyacrylamide gel 
electrophoresis, C 1 fragments isolated with IgG aggregates under the conditions used 
for the  isolation  of the  Fcy-binding membrane protein  showed  one large  peak of 1064  FcT-BINDING PROTEIN FROM LEUKEMIC B CELLS 
58,500 daltons and no predominant peak in the 28,000-dalton region.  (e) EA prein- 
cubated in EDTA-ME lysates displayed brilliant fluorescence with antisera directed 
against the Fcy-binding protein, but not with anti-Clq sera. 
The data presented here show that the Fc~,-binding protein that we isolated from 
leukemic B cells consists of a single polypeptide chain and has an apparent mol wt of 
28,000 and a pI of 5.5. This structure has only one binding site, and its linkage to the 
cell  membrane  is  apparently  mediated  by  divalent  cations  and  disulfide  bridges. 
These  features  suggest  that  the  isolated  Fcy-binding  protein  is  not  an  integral 
membrane  protein,  as  defined  by  Singer  et  al.  (39),  but  rather,  an  associated 
membrane protein; it represents either a  complete receptor molecule or at least the 
fragment of Fcy receptors that is responsible for binding to the Fc portion of IgG. The 
28,000-dalton Fc~,-binding protein tends to aggregate, probably to tetramers, in the 
absence of ME and might be expressed on the cell membrane in the form of tetramers. 
Summary 
A  selectively Fcy-binding protein was  isolated from purified and  radioiodinated 
cell membranes from two cases of B-type chronic lymphocytic leukemia and one case 
of B-type prolymphoeytic leukemia by binding to IgG aggregates, horseradish per- 
oxidase-anti-peroxidase  IgG  complexes,  and  sheep  erythrocyte  membrane  sheets 
densely coated with IgG. This protein could not be isolated from the cell membranes 
of an  Fcl,-receptor-negative chronic  lymphocytic leukemia  of the  T  type  or  from 
membranes of human erythrocytes. The Fcy-binding protein was efficiently solubi- 
lized by a  mixture of Na-EDTA and 2-mercaptoethanol, but not with one of these 
agents alone, indicating that both divalent cations and disulfide bridges are involved 
in the linkage of the Fcy-binding protein to the cell membrane.  In sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis, the Fcy-binding protein revealed an  ap- 
parent tool wt of 28,000, and in isoelectric focusing it showed an isoelectric point of 
5.5. The electrophoretic mobility of the 28,000-dalton protein did not change after 
reduction and alkylation. It was determined that the NH2-terminal amino acid of the 
protein was glycine. The isolated protein was unable to agglutinate antibody-coated 
erythrocytes. These findings suggest that  the 28,000-dalton IgG-affined protein was 
composed of one polypeptide chain with one Fc~,-region-specific binding site. When 
exposed  to  O2-enriched  buffer lacking  reducing  agents,  the  28,000-dalton  protein 
aggregated to a  115,000-dalton molecule. The isolated Fc~,-binding protein proved to 
be different from Clq or its subunits. 
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